Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Week In Review: Grifols Pays $1.9 Billion For 26% Stake In Shanghai RAAS

Article By:
ChinaBio® Today
Saturday, March 9, 2019 4:13 PM EDT
Grifols, a Barcelona maker of plasma-based medicines, acquired a 26% stake in Chinese blood plasma company Shanghai RAASfor $1.9 billion in a non-cash deal. Grifols will exchange a 45% ownership in Grifols Diagnostic Solutions for the RAAS stake.
Grifols, S.A.: Success Is In Its Blood

Article By:
Fredrik Arnold
Friday, February 23, 2018 6:59 AM EDT
Today I'm reviewing a biotechnology company, Grifols, S.A. Its trading ticker symbol is GRFS.
In this article: GRFS
3 Biotechnology Stocks To Buy On This Biotechnology Breakout

Article By:
Taki Tsaklanos
Thursday, June 22, 2017 9:11 PM EDT
The biotechnology stock sector is breaking out. After 20 months of consolidation “everyone” forgot about biotechnology stocks, the former leading stock market sector. As it always goes the bull breaks out once all interest is gone.